抗GD2免疫治疗视网膜母细胞瘤的前景
Xinlong Zhang1,2,3, Wulin You4,5, Yuntao Wang1,2,3
1Affiliated Hospital of Shandong Second Medical University,School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
Frontiers in immunology
|December 2, 2024
概括
针对disialoganglioside (GD2) 的免疫疗法为视网膜母细胞瘤治疗提供了一个有希望的,低毒性的替代方案. 研究探讨基于GD2的单克隆抗体,CAR-T疗法,疫苗和纳米粒子,以改善患者的治疗结果.
科学领域:
- 眼科医生 眼科 眼科
- 儿科瘤学 儿科瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 视网母细胞瘤是最常见的儿科眼睛瘤.
- 目前的治疗方法 (化疗,手术,放射治疗) 有显著的不良影响.
- 免疫疗法提供了一个低毒性的替代方案,有可能改善生活质量.
研究的目的:
- 审查针对视网膜母细胞瘤的disialoganglioside (GD2) 的免疫治疗策略.
- 评估基于GD2的免疫疗法的临床前和临床数据.
- 讨论这些方法的未来前景和局限性.
主要方法:
- 临床前研究和临床试验的文献综述.
- 专注于disialoganglioside (GD2) 作为一个治疗点.
- 对抗GD2单克隆抗体,CAR-T疗法,GD2疫苗和纳米粒子的分析.
主要成果:
- 滴立方化物 (GD2) 在视网膜母细胞瘤细胞上表达,使其成为一个可行的点.
- 反GD2单克隆抗体 (Dinutuximab) 在类似的癌症中显示出有效性.
- 卡特-T疗法,GD2疫苗和纳米粒子正在成为潜在的治疗方法.
结论:
- 针对GD2的免疫疗法对视网膜母细胞瘤治疗具有显著的前景.
- 需要进一步的研究来克服目前的局限性并优化治疗策略.
- 免疫疗法提供了一种潜在的更安全,更有效的方法来改善患者的预后.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.3K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
7.9K
相关概念视频
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476